Zydus Lifesciences Q3 Results FY2023, PAT at Rs. 6229 million

Shreya_Anaokar Shreya Anaokar

Last Updated: 6th February 2023 - 04:45 pm

Listen icon

On 3rd February,  Zydus Lifesciences announced its results for the third quarter of FY2023.

Key Highlights:

- Revenue from Operations at Rs. 43,623 million, up 20% over last year. 
- Research & Development (R&D) investments for the quarter stood at Rs. 3,435 million (7.9% of revenues). 
- EBITDA for the quarter was Rs. 9,560 million, up 27% yoy. EBITDA margin for the quarter was 21.9% against 20.6% in Q3 FY22. 
- Net Profit for the quarter was Rs. 6,229 million, up 24% yoy. 

Business Highlights:

- The Indian business registered revenues of Rs. 16,436 million, up by 13% yoy. 
- The formulation business, registered revenues of Rs. 12,316 million, up by 14% yoy.
- Consumer Wellness business registered revenues of Rs. 4,120 million, up by 8 % yoy
- US formulations business registered revenues of Rs. 19,250 million, up by 29% yoy 
- Emerging Markets (EM) formulations business continued to deliver double digit growth as it registered revenues of Rs. 3,078 million, up 15% yoy.
- Europe formulations business registered revenues of Rs. 705 million, up by 4% yoy.
- API business registered revenues of Rs. 1,881 million, up 14% yoy.
- Alliances & Others registered revenues of Rs. 248 million, down 55% yoy.

Commenting on the results, Dr. Sharvil Patel, Managing Director - Zydus Lifesciences Limited said: “We are pleased with our Q3 FY23 performance showcasing robust growth across key businesses and improved profitability. With India Formulations in a double-digit growth trajectory and US business continuing to build traction, portfolio execution will sustain growth momentum. We aim to enhance profitability steadily going ahead while remaining committed to build long term growth levers. Our commitment to maintaining high quality standards and an agile supply chain positions us well to capitalize on our R&D pipeline and advance our innovation efforts.”
 

FREE Trading & Demat Account
Open FREE Demat Account with endless opportunities.
  • Flat ₹20 Brokerage
  • Next-gen Trading
  • Advance Charting
  • Actionable Ideas
+91
''
By proceeding, you agree to our T&Cs*
Mobile No. belongs to
hero_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form